Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01698957 · ClinicalTrials.gov registry record
Maternal Uterine Artery Doppler Study
A clinical trial, sponsored by Obstetrix Medical Group.
- Completed
- Registry status
- 52
- Enrollment target
NCT01698957 is a clinical trial that has completed, run by Obstetrix Medical Group. The registered enrollment target is 52 participants.
The verdict
NCT01698957 has completed, sponsored by Obstetrix Medical Group.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
The purpose of this study is to detect if adding resistance to maternal blood flow from the arm will help increase the blood flow through the uterine arteries to the placenta and the baby.
Interventions
- OTHER Any patient eligible for an Ultrasound greater than or equal to 18 weeks gestation without a fetal or uterine anomaly.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01698957
The ClinicalTrials.gov registry entry for NCT01698957 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Obstetrix Medical Group, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Any patient eligible for an Ultrasound greater than or equal to 18 weeks gestation without a fetal or uterine anomaly. is the first listed.
NCT01698957 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01698957 about?
NCT01698957 is a clinical study titled "Maternal Uterine Artery Doppler Study". The purpose of this study is to detect if adding resistance to maternal blood flow from the arm will help increase the blood flow through the uterine arteries to the placenta and the baby.
What is the current status of trial NCT01698957?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2012-09. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01698957?
The interventions under investigation include: Any patient eligible for an Ultrasound greater than or equal to 18 weeks gestation without a fetal or uterine anomaly. (OTHER).
Who is sponsoring clinical trial NCT01698957?
This trial is sponsored by Obstetrix Medical Group, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.